Oxford's Boltz-1 Interpretability Study, NVIDIA's JEPA-DNA, and Rostock's CytoBERT
Kiin Bio's Weekly Insights
Kiin Bio Weekly
Where AI meets Life Science
Live Last read · last published · next check
Latest posts
Ai2 & Asta: Letting AI Surprise Itself
Deep Dive | Edition 24
Memorial Sloan Kettering's ScreenShot, Zhejiang University's RetFold, and UNC Chapel Hill's SABLE
Kiin Bio's Weekly Insights
Talus Bio's Ptarmigan-1, the Human Cancer Models Initiative, and Vilya Research's Vilya-2
Kiin Bio's Weekly Insights
Savana: Turning Clinical Text into Regulatory-Grade Evidence
Deep Dive | Edition 23
NYGC's Pan-human Azimuth, Zheng Lab's AAMFM, and Meijers Lab's ML-aided antibody platform
Kiin Bio's Weekly Insights
A Primer on Market Access
Why drugs miss commercial forecasts, and what earlier alignment between clinical and market access teams could fix
Stanford's scVision, Ohio State's conDitar-dev, and the AllTheBacteria consortium
Kiin Bio's Weekly Insights
MolJSON: Teaching Language Models to Speak Molecule
Deep Dive | Edition 22
Vilya Research's Vilya-1, TU Munich's TWIN, and Stanford's UCE
Kiin Bio's Weekly Insights
Scigantic: The Platform That Democratizes Access to Large-Scale Data
Deep Dive | Edition 21